Journal Article

Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder

Xie, Haiyi, Ford, James C, Roth, Robert M, Hickey, Sara M, Khokhar, Jibran Y, Trask, Christi, Brunette, Mary F, Zeffiro, Thomas, Park, Soo Hwan

2025

Overview

Up to 43% of people with schizophrenia have a lifetime cannabis use disorder (CUD). Tetrahydrocannabinol (THC) has been shown to exacerbate psychosis in a dose-dependent manner, but little research has assessed its effects on schizophrenia and co-occurring CUD (SCZ-CUD). In this double-dummy, placebo-controlled trial (total n = 130), we hypothesized that a modest dose of THC would worsen cognitive function but not psychosis. Effects of single-dose oral THC (15 mg dronabinol) or smoked 3.5% THC cigarettes vs placebo in SCZ-CUD or CUD-only on positive and negative symptoms of schizophrenia (only for SCZ-CUD), cognition, and drug experiences assessed several hours after drug administration. SCZ-only and healthy control participants were also assessed. Drug liking was higher in THC groups vs placebo. Neither smoked THC nor oral dronabinol predicted positive or negative symptom subscale scores 2 and 5 h, respectively, after drug exposure in SCZ-CUD participants. The oral dronabinol SCZ-CUD group, but not smoked THC SCZ-CUD group, performed worse than placebo on verbal learning (B = -9.89; 95% CI: -16.06, -3.18; P = .004) and attention (B = -0.61; 95% CI: -1.00, -0.23; P = .002). Every 10-point increment in serum THC + THCC ng/ml was associated with increased negative symptoms (0.40 points; 95% CI: 0.15, 0.65; P = .001; subscale ranges 7-49) and trends were observed for worse positive symptoms and performance in verbal learning, delayed recall, and working memory. In people with SCZ-CUD, a modest single dose of oral THC was associated with worse cognitive functioning without symptom exacerbation several hours after administration, and a THC dose-response effect was seen for negative symptoms.

• Publisher: Oxford University Press
• Subject: Adult / Cognitive Dysfunction - chemically induced / Comorbidity / Dose-response relationship / Double-Blind Method / Dronabinol - administration & dosage / Dronabinol - adverse effects / Dronabinol - pharmacology / Drug dosages / Female / Humans / Male / Marijuana / Marijuana Abuse - complications / Marijuana Abuse - epidemiology / Middle Aged / Psychosis / Regular / Schizophrenia / Schizophrenia - complications / Schizophrenia - drug therapy / Schizophrenia - epidemiology / Schizophrenia - physiopathology / Tetrahydrocannabinol / THC / Verbal learning / Young Adult